Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 13, 2021
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification
Charles Ronsin, Marie Georges, Agnès Chapelet-Debout, et al.
Annals of the Rheumatic Diseases
|
May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides
Benjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Medicine
|
July 30, 2015
Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases
Maxime Dauvergne, Anissa Moktefi, Marion Rabant, et al.
Kidney International
|
June 19, 2026
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease
Dominique Joly, Moreno Ursino, Frank Bienaimé, et al.
The Journal of Experimental Medicine
|
March 28, 2012
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Laureline Berthelot, Christina Papista, Thiago T Maciel, et al.
The New England Journal of Medicine
|
November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
Loïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Kidney International
|
June 25, 2022
Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
Sophie Chauvet, Jill J Hauer, Florent Petitprez, et al.
Clinical and Experimental Rheumatology
|
April 7, 2016
Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life
Grégory Pugnet, Christian Pagnoux, Benjamin Terrier, et al.
British Journal of Clinical Pharmacology
|
May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity
Naïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Emerging Infectious Diseases
|
June 21, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017
Benoît Travert, Antoine Dossier, Matthieu Jamme, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 13, 2021
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification
Charles Ronsin, Marie Georges, Agnès Chapelet-Debout, et al.
Annals of the Rheumatic Diseases
|
May 5, 2018
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides
Benjamin Terrier, Christian Pagnoux, Élodie Perrodeau, et al.
Medicine
|
July 30, 2015
Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases
Maxime Dauvergne, Anissa Moktefi, Marion Rabant, et al.
Kidney International
|
June 19, 2026
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease
Dominique Joly, Moreno Ursino, Frank Bienaimé, et al.
The Journal of Experimental Medicine
|
March 28, 2012
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Laureline Berthelot, Christina Papista, Thiago T Maciel, et al.
The New England Journal of Medicine
|
November 6, 2014
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
Loïc Guillevin, Christian Pagnoux, Alexandre Karras, et al.
Kidney International
|
June 25, 2022
Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy
Sophie Chauvet, Jill J Hauer, Florent Petitprez, et al.
Clinical and Experimental Rheumatology
|
April 7, 2016
Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life
Grégory Pugnet, Christian Pagnoux, Benjamin Terrier, et al.
British Journal of Clinical Pharmacology
|
May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity
Naïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Emerging Infectious Diseases
|
June 21, 2021
Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017
Benoît Travert, Antoine Dossier, Matthieu Jamme, et al.
Page
of 13